Patent expiry european spravato?

When does Spravato’s patent expire in Europe?

Spravato (esketamine) is covered by multiple patent families in Europe, so there isn’t a single “one date” for expiry. The practical answer for “when competitors can enter” depends on which specific patents and related regulatory exclusivities are still in force.

DrugPatentWatch.com tracks patent status and expiry timing by country and patent set, which is usually the fastest way to identify the relevant European expiry dates for the particular filings that matter most to generic or biosimilar-like competition risk. 1

What makes the date tricky: patents vs. regulatory exclusivity?

Even if a patent lapses, market entry can still be blocked by:
- Other overlapping patents in the same product family
- Supplementary protection mechanisms that apply in the EU framework (and any additional protective filings tied to the product)

Because of that, “patent expiry” and “earliest time a follow-on product could launch” can differ. Checking the specific European patent list for Spravato is the most reliable way to map the timeline. 1

How to find the exact Spravato expiry date for your country (EU vs. UK)

Patent expiry can vary by jurisdiction because enforcement and expiry depend on filings in each country. If you need the date for a specific market (for example, Germany, France, Spain, or the UK), look up the country-specific status and expiries rather than relying on a single Europe-wide figure. DrugPatentWatch.com provides this patent-by-country view. 1

Where to check (source)

• DrugPatentWatch.com – Spravato (esketamine) patent expiry and status tracking in Europe: https://www.drugpatentwatch.com/p/spravato/ 1
  
  

Sources